The authors found that co-injection of smn-MO and chodl mRNA rescued motor axon abnormalities in 28 h post-fertilization (hpf) embryos, indicating that chondrolectin is another modifier of SMA disease [45]. The gene discussed is SMN2; the disease is proximal spinal muscular atrophy.